ATTORNEY ADVERTISING: is owned and operated by Injury Claims, located at 930 Sylvan Ave Ste 110 Englewood Cliffs, NJ 07632-3321. Injury Claims is a legal advertising service and not a law firm or a lawyer referral service. We connect individuals seeking legal services with participating attorneys who pay to be included in this service. Submitting a form, calling a listed number, or contacting us does not create an attorney-client relationship. An attorney-client relationship is only formed through a written agreement with a law firm. Do not submit confidential or time-sensitive information. This communication does not offer medical advice, never stop taking a prescribed medication without consulting a doctor. Information submitted through this site may not be protected by attorney-client privilege and is subject to our Privacy Policy. Do not submit confidential or time-sensitive information through this site. Some cases may be referred to co-counsel or handled jointly, subject to client consent and in compliance with applicable state laws. Participating attorneys may not be available in all states. This advertisement may not be available in jurisdictions where it violates local rules. No representation is made that the quality of services is greater than those of other attorneys. Images may be dramatized or depict models. A complete list of participating attorneys is available here. Free background information is available upon request. Advertising paid for by participating attorneys in a joint advertising program.
Disclaimer: Paid legal advertisement: Martin Schmidt, Attorney at Law (3033 Fifth Ave #335, San Diego, CA 92103) and David Hiden, Attorney at Law (4241 Jutland Drive, Suite 200, San Diego, CA 92117) are responsible for this advertisement as it applies to California residents and California cases. A California-licensed attorney is associated with CA cases. Ads may use paid actors, dramatizations, and AI-generated imagery for illustration only and does not depict real clients or events. No guarantee or prediction of outcome is made. Cases may be referred to other attorneys.
Patients are filing lawsuits against Novo Nordisk, the maker of Ozempic (semaglutide), alleging the drug causes severe and unexpected side effects. The two primary injuries at the center of the Ozempic lawsuit are gastroparesis (stomach paralysis) and vision loss linked to optic nerve damage. Claims argue that the manufacturer failed to provide adequate warnings about these risks, leaving patients vulnerable to life-altering harm.
This guide explains who qualifies for an Ozempic injury lawsuit, the key medical complications at issue, evidence that supports claims, potential settlement factors, recent lawsuit updates, and how the legal process works.
Who Qualifies for an Ozempic Lawsuit?
Used Ozempic (semaglutide) for diabetes or weight loss
Later diagnosed with gastroparesis (stomach paralysis) or vision loss tied to optic nerve damage
Experienced long-term complications, hospitalizations, or permanent disability
1. Gastroparesis (Stomach Paralysis): Patients allege that Ozempic causes severe gastric slowing, leading to chronic nausea, vomiting, abdominal pain, malnutrition, and hospitalizations. Some cases require feeding tubes or surgical intervention.
2. Vision Loss / Optic Nerve Damage: Lawsuits also claim Ozempic use is linked to optic nerve ischemia and permanent vision loss. Patients report sudden or progressive blindness, blurred vision, or other sight-threatening complications.
What Evidence Supports an Ozempic Case
Prescription history documenting Ozempic use (dose, duration)
Medical records confirming gastroparesis or optic nerve damage diagnosis
Hospitalization reports or surgical interventions tied to GI complications
Ophthalmology records for vision loss claims
Impact documentation: lost wages, daily limitations, long-term disability
Ozempic Lawsuit Settlements & Key Factors
Since litigation is ongoing, no global Ozempic settlement has been reached. Factors that may influence case value include:
Type of injury: gastroparesis vs. permanent vision loss
Venue & jury trends: some courts award higher damages in pharmaceutical cases
* Educational only; settlement outcomes vary by case facts and jurisdiction.
Ozempic Lawsuit Updates – June 2026
December 9, 2025: The MDL involving Ozempic and other GLP-1 weight-loss medications continued to grow in November, with 27 new cases added. The total number of pending filings has reached 2,947, reflecting ongoing adoption of these drugs and a rising number of claims alleging inadequate warnings about potential side effects.
November 11, 2025: Ozempic / GLP-1 MDL reaches 2,914 pending cases, an increase of 800 since August 1, averaging roughly 200 new filings per month.
September 30, 2025: California woman files Wegovy lawsuit alleging severe gastrointestinal injuries, including ileus and gastroparesis, claiming Novo Nordisk failed to warn about serious risks while marketing the drug as a safe long-term weight-loss treatment.
September 21, 2025: Shift to NAION claims as plaintiffs pivot away from gastroparesis and focus on sudden vision loss tied to non-arteritic anterior ischemic optic neuropathy (NAION). Regulatory warnings and the severity of the injury make these cases stronger for trial.
September 17, 2025: Master and Short Form Complaints proposed in the Ozempic MDL, streamlining filings and organization. Defendants have 60 days to respond, with motions to dismiss under tight control.
September 11, 2025: Lilly seeks NAION MDL to consolidate vision loss cases involving Ozempic, Mounjaro, Trulicity, and Wegovy. The motion requests Judge Karen Marston, already presiding over the GI injury MDL, to oversee the new docket.
September 6, 2025: New claims criteria set as Judge Marston clarifies the litigation will focus on NAION vision injuries and gastroparesis confirmed by diagnostic testing.
September 5, 2025: FDA green-lists suppliers of raw materials for compounded GLP-1 drugs, restricting imports from unauthorized manufacturers.
September 1, 2025: FDA approves Wegovy for fatty liver disease (MASH), marking the first GLP-1 therapy cleared for this condition.
August 15, 2025: Major rulings issued by Judge Marston narrow gastroparesis claims to cases with objective testing but allow labeling, warranty, and fraud-based allegations to proceed against Novo Nordisk and Eli Lilly.
Early 2025: Federal lawsuits continue to grow as patients allege Ozempic causes gastroparesis and vision loss. Judges are reviewing case coordination requests.
2024: Medical studies linked GLP-1 drugs like Ozempic to severe delayed gastric emptying and reports of optic nerve damage.
2023: Early filings alleged permanent injuries including stomach paralysis and vision loss, with claims focused on failure to warn patients of these risks.
We update this section monthly with MDL activity, notable filings, and verdicts.
How the Ozempic Lawsuit Process Works
Free evaluation: Provide prescription history and medical records.
Investigation: Attorneys review evidence and consult gastroenterology/ophthalmology experts.
Filing: Claims may be filed individually or coordinated in federal MDL proceedings.
Discovery & negotiation: Exchange medical records, expert opinions, explore settlement or mediation.
Resolution: Settlement, mediation, or trial depending on case facts.
Gastroparesis is a condition where the stomach muscles are paralyzed or weakened, preventing normal digestion. Symptoms include nausea, vomiting, abdominal pain, and severe complications requiring hospitalization.
How is Ozempic linked to vision loss?
Some lawsuits allege that Ozempic may damage the optic nerve, leading to partial or permanent blindness. Ophthalmology records are key to proving causation.
Who qualifies for an Ozempic lawsuit?
Patients who used Ozempic and later developed gastroparesis or vision loss may qualify, especially if supported by medical documentation.
Are settlements available yet?
No global settlement exists yet. Individual case outcomes may vary based on severity, evidence, and jurisdiction.
Do I have to pay upfront?
No. Most firms work on contingency—you pay nothing unless there is a recovery.
Injury Claims keeps you informed about lawsuits large and small that could affect your daily life. We simplify the complexities of Class Action Lawsuit, open Class Action Lawsuit settlements, mass torts, and individual cases to ensure you understand how these legal matters could impact your rights and interests.
Legal Updates That Matter to You
If you think a recent legal case might affect you, action is required. Select a Class Action Lawsuit or Class Action Lawsuit settlement, share your details, and connect with a qualified attorney who will explain your legal options and assist in pursuing any compensation due. Take the first step now to secure your rights.
Why Trust InjuryClaims.com?
InjuryClaims.com is a consumer legal resource built for transparency, regulatory compliance, and responsible attorney connections. We work with licensed law firms nationwide handling mass tort, class action, and mass arbitration matters.
Florida Bar–Registered Qualifying Provider: We are listed as a Qualifying Provider with Current Reports with The Florida Bar, operating in compliance with applicable attorney advertising regulations.
Top Law Firm Partners: We collaborate with nationally recognized plaintiff firms, including Milberg, The Driscoll Firm, The Russo Firm, Dolman Law Group, and JJ Legal. Our partner firms litigate mass tort, class action, and coordinated mass arbitration cases nationwide.
Industry Engagement: Our team regularly attends major legal conferences such as Mass Torts Made Perfect (MTMP) and National Trial Lawyers Summit to stay informed on evolving litigation trends and arbitration developments.
Secure & Confidential: All information submitted through InjuryClaims.com is encrypted and confidential and shared only with licensed attorneys evaluating potential claims.
Editorial Standards & Legal Contributors: Our articles are written and reviewed by experienced legal writers and litigation industry professionals. Learn more on our About Us page.
